Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · IEX Real-Time Price · USD
1.630
-0.060 (-3.55%)
At close: Jul 19, 2024, 4:00 PM
1.650
+0.020 (1.23%)
Pre-market: Jul 22, 2024, 9:09 AM EDT
Clover Health Investments Employees
Clover Health Investments had 552 employees as of December 31, 2023. The number of employees decreased by 104 or -15.85% compared to the previous year.
Employees
552
Change (1Y)
-104
Growth (1Y)
-15.85%
Revenue / Employee
$3,356,643
Profits / Employee
-$289,719
Market Cap
809.19M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 552 | -104 | -15.85% |
Dec 31, 2022 | 656 | -24 | -3.53% |
Dec 31, 2021 | 680 | 222 | 48.47% |
Dec 31, 2020 | 458 | 119 | 35.10% |
Dec 31, 2019 | 339 | - | - |
Related Stocks
Company Name | Employees |
---|---|
The Pennant Group | 5,791 |
CureVac | 1,172 |
Atrion | 712 |
Cytek Biosciences | 676 |
Standard BioTools | 539 |
Aurinia Pharmaceuticals | 300 |
Cogent Biosciences | 164 |
Olema Pharmaceuticals | 74 |
CLOV News
- 25 days ago - Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement - GlobeNewsWire
- 5 weeks ago - CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year - GlobeNewsWire
- 7 weeks ago - Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers - GlobeNewsWire
- 2 months ago - Here's why Clover Health stock price spiked after earnings - Invezz
- 2 months ago - Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024 - GlobeNewsWire
- 3 months ago - Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer - GlobeNewsWire
- 3 months ago - Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions - GlobeNewsWire